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Differentiation associated modulation of K-FGF expression in a human 
Rcccivcd R Januury 1991 
The human teratocarcinoma ccl1 line Tcra 2 can bc induced IO di.qcrcJrtiatc in vitro after exposure to rctinoic acid. We show in this pq%r thtrt 
whereas the K-FGF oncogcnc is cxprrsscd in undiffcrcnti;ited cells, addition of retinoic acid rapidly (~60 min) downrcgulutcs the expression of 
this pcnc. However, when cells are cultured in AA for an extended pcricsd of timr (> I5 days) KSFGF transcripts rcilppcar. WC also report that 
K-FGF is expressed in approximately one-third of primary humen gclm cell tumours but no\ in the corrcspondiny normal tcsticuhir tissue. 
K-FGF; Teralocarcinoma 
1. INTRODUCTION 
The heparin binding growth factor family now com- 
prises a number of structurally related polypeptides 
which influence many aspects of cellular physiology, 
differentiation and proliferation. The acidic and basic 
fibroblast growth factors, originally isolated from 
pituitary and central nervous system respectively, are 
potent mitogens, both in vitro and in vivo [l] and since 
their discovery have been shown to stimulate prolifera- 
tion of a wide variety of cells in tissue and organ culture 
[2,3]. The FGFs are also interesting in the light of their 
diveree deve!opmental effects. Synthesis of heparin bin- 
ding growth factors occurs both in perimplantation 
stages of mammalian embryogenesis and later during 
orgsonogenesis. In both these situations there is cir- 
cumstantial evidence for a pleiotropic response of 
target cells to the factor: different concentrations of the 
factor leading to proliferation, cell migration and dif- 
ferentiation f4,5]. Not only are these processes impor- 
tant in morphogenesis but also in the metastasis and 
angiogenic properties of turnours, and there is strong 
evidence that FGF or related molecules are potent 
stimulators of the capillary endothelial cell response to 
tumours 131. 
Within recent years the FGF family has expanded to 
include proteins encoded by at least 7 different genes. In 
addition, genes encoding FGF-receptors have been 
recently characterized. Genes encoding the FGF 
homologues K-FGF?hst, int-2 and FGF-5 were original- 
ly isolated as oncogenes by DNA tsansfection assay, 
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and sequence analysis has revealed the homology of the 
predicted proteins with prototype FGFs [6-l 11. The ex- 
pression of int-2 and K-FGF during embryogenesis i  
confined to distinct process related time windows 
[12,13] suggesting a potential regulatory role in 
development, Maintenance of the balance between dif- 
ferentiation and proliferation is essential for the pro- 
gressive growth of stem cell driven differentiating 
systems such as the embryo or indeed a tumour. We 
have attempted to assess the contribution of auto or 
paracrine K-FGF action in a model system derived from 
a human developmental tumour, 
The teratocarcinoma cell line Tera 2 cl-13 [14] was 
clonally derived from Tera 2 [ 151 which was itself 
established from a pulmonary metastasis of a testicular 
teratocarcinoma. In response to retinoic acid cells in 
monolayer culture terminally differentiate to form a 
mixture of cell types expressing characterisr.ic markers. 
Among these cells are neurone-like cells that express 
tetanus toxin receptors and neurofilaments [14]. When 
the undifferentiated cells are injected into nude mice, 
connective tissue, epithelia and neurones can be 
detected in the tumours that develop. This and other 
evidence [16] suggests that Tera 2 can express the 
critical properties which might be expected of a cell line 
reflecting an early human embryonic stem cell. 
We have established that Tera-2 expresses mRNA for 
K-FGF and have examined the expression of the K-FGF 
gene in differentiating Tera-2 cells. We report here that 
treatment with retinoic acid rapidly downregulates the 
gene but that transcripts reappear after 15 days. 
2:. MATERIALS AND METHODS 
2.1. Cell culture 
Cells were maintained in alpha modified minimum essential 
mcdhrnr la&in@ nuelcaridcs and dcuxynuelcowidss (Gibea, UK) and 
canlainin& 10% hear~lnuc~iva~ed rm car serum. They wcrc cultured 
as dsneribed by Thompm cI al, [l4). Undiffcrcniintcd ccllr were 
rauGnely plnled 81 1 x IO’ cells per 90 man dish r0r ptrewlh arwryx. In- 
ducrian or diffeercnrinUon was nchievcd by plating cclla in rhe prerencr 
0rzx 10-s nil trttm’ rrlinaic w/d (Ea%unnn Kodak) dilurcd from a O,l 
M stock in dime~fiylsulphoxide, 
Cells were harvested by rinsing with Cal* /Ms’ *+ec pholcphate 
blJf!k!d saline and incubation in I aoluIion 0r O,l25% (w/v) rrypsin 
irr PBS ronrainin# Or5 mM EBTA, The eclk were spun in Eppendorf 
tubes to give approxiinw~cly I X lO6cclir per rnbe. The cells were rhcn 
incubated in 20~1 ofnranoclonal antibody W&/32 culture supcrnntnnr 
(141 rhal had brcn diluted pre~+xJsly lo !/IQ 0r its origin:11 vsluinc 
with Ca’ * /Mga” -free PRS conraining radium axide and 2% (v/v) 
fetal d serum, After incubnlion for 45 niin nf 4*C, 0,s ml d rhc 
above r&de/serum/PBS solution was addtd and the sampler spun, 
The cell peller wns resuspended in 20 bl of JJ I /30 dilution of rabbit nn- 
ti mouse inwunoglabulin Gfluorcsccin iso~hiocyanatc for 45 nrin 
arid viewed under n fluorcsscnce microscope. At lcasr 200 cells were 
counted for each sample. 
Tlrc Herman EC-rcll spreifie antibody GCTM-2 117) was used JIS 
described at II final dilurion of 1:50 on cells grown in parallel to cx- 
pcrimenral cuhures on covcrslips gclntinised by overnight freatmcnt 
with 0,5% w/v gelnlin (Sigma). 
L3. Isolrtrion of tnlBNA 
Cells were washed in situ with 5 ml of prewarmed PBS and lyscd 
in 2 mi per dish of 4 M guanidinium thiocynnatc (PhJka) 25 nrM 
trisodiumcirratc (pH 7.0), 0,I M Ij.mcrcaptoctlranoI, 0.5% Sarkosyl 
(BDH) (GuSCN-buffer). Tissue samples from resriiular tlJmours were 
homogenized in GusSCN-buffer with a high speed Ultra Turrax 
homogenizer, The lysnres were layered onlo a 2.2 ml cushiori of 5.7 
ml CsCI, 0.1 M EDTA @l-I 8.0) in a Beckman SW40 tube and ten- 
trifugcd at 33 OOO rpm in a SW40Ti rotor for 20 h at IS% The 
resulting pelle[ was washed, taken up in 100 pl of filtered 
dietlJylpyrocilrbonale.trentcd waler and precipitated with OS3 M 
sodium acetate and 20 ~1 of ethanol. Polyadcnylatcd RNA was subsc- 
quently extracted by the use of oligo (dT) cellulose as described in 
detail in [,lS]. 
2.4. Norrkrn blortlng 
§ fig of polyndcnylated RNA from each sample was analyscd by 
Northern blotting as previously described [i9], 
2.5. DNA.probes 
The K-FCiF/hst probe was 285 bp Sacl/Uindlll fragment from 
pORF1 [20] generously provided by Professor Takashi Sugimura. 
The glyceraldehydc 3.phosphate dehydrogenase probe (GAP) was a 
murine cDNA and was the kind gift of Dr Peter Curtis, Wistar In- 
stitute. 
3. RESULTS AND BEXXJSSION 
Undifferentiated Tera 2 cells in monolayer culture 
multiply exponentially with an approximate population 
doubling time of 24 h [ZO]. In contrast, if cells are 
plated in the presence of 2 x IO-’ Nl retinoic acid, 
overall cell numbers cease to increase by 1% to I.8 days 
and the majority of cells become arrested in Gl as 
estimated by cytopllotometry [20]. In the experiments 
described here less than 6% of the undifferentiated cells 
expressed W6/32 reactivity (it> 200) and the general 
lack of expression of HLA-A&C common deter- 
minants is consistent with their undifferentiated 
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Fig, I. The kin&s Or nppcaranee 0r the diffcrsnlinlion marker 
We/32 rractivhy after cxpos\Jre of Tcra 2 ccllr lo 2 x IO” ’ M rctliioic 
acid, 
phenotype. After addition of retinoic acid, the ccl1 cycle 
rapidly lengthens, Fig. 1 shows an estimate of the rate 
of acquisition of ML&A,B,C common determinants 
during a 14 day exposure to retinoic acid. By 12 days 
approximately 4OOi’o of the cells expressed antigens that 
reacted with the W6/32 antibody and by 13 days 80% 
of the cells reacted. These figures were confirmed by 
staining populations of undifferentiated and differen- 
tiated (15 d) cells using the antibody GCTM-2 which 
reacts only with a heparan sulphate proteoglycan on the 
surface of teratocarcinoma stem cells. The undifferen- 
tiated component of the 15 d RA-treated population 
was confined to less than 10% of the cells examined 
(>200). 
Poly A + RNA was prepared from cultures exposed to 
retinoic acid for 60 rnin, 5, 12 and 15 days together with 
samples of undifferentiated cells. Fig. 2 shows that the 
K-FGF transcript has almost disappear,ed after 60 min 
exposure to retinoic acid, indicating a very rapid 
downregulation of this gene. This finding confirms a 
previous preliminary report I211 and is also consistent 
with a recent report hat another human embryonal car- 
cinoma cell line NT2/D1 downregulates K-FGF- 
expression after § days gxposure to retinoic acid [22]. 
However, if the cells were xposed to retinoic acid for 
an extended period of time (i.e. 15 days) the 3 kb K- 
FGF transcript reappears. This finding: has not been 
previously reported and suggests that I[(:-FGF gene ex- 
pression may represent a multifaceted function in the 
control of growth and differentiation. By using two 
separate biochemical criteria for differentiation it is 
clear that the reappearance of transcripts after 15 days 
of differentiation is not the result of a small RA 
unresponsive undifferentiated population taking over 
the cultures. Addition of retinoic acid in different pat- 
terns, either once at the initiation of differentiation or 
on alternate days through the experiment did not affect 
the results (data not shown). It has indeed been shown 
that K-FGF expression in the embryo is stage-specific 
and our observations on an embryonal carcinoma cell 
rharwa that the expected 3kb transcript cauld be obrerv- 
ed in two I;cmiikmars; and one rmkk=ynnal can-cinoms. 
Na K-FGF rranxcriprn cauld be &tccrcd in 7 ssminomas; 
ar in nermnl rsarlculnr tissue. These data confirm a 
preliminary report by Yashida et al. [23] who failed to 
dcteer tranacriptn from this gene in any other tissue but 
in 5 human germ cell turnours. Taken together chcoc 
data sug@xt that K-FGF playa R pivatal rele in ctn- 
bryagcncsix as wrll a$ in the development of germ cell 
turnours. 
Fig. 2. Expression of K-FGF in cells cxpo~d to rctinois acid for dif- 
ferent periods of lhnc as cxamincd by Northern blotting. After prc 6. 
ing with KJGF cDNA, the filter was stripped of bound probe a :d 
rchybridised with a cDNA-probe for gtyccraldehyde %phosphnrc 
dehydrogcnnse (GAP), 
line in vitro may well indirectly reveal crucial embryonic 
developmental pathways. 
To compare the expression of K-FGF in Tera 2 cells 
with the phenotype of primary germ cell tumours we 
purified polyA+ RNA from 10 surgical specimens of 
human testicular tumours (9 seminomas and 1 em- 
bryonal carcinoma) and from normal testis. Fig. 3 
3 kt, 
Fig. 3. Expression of K-FGF in a panel of surgical specimens from 
human berm cell ttnnours; l-7, and 9-10 seminomas, 8, embryonai 
carcinoma, 
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